Literature DB >> 8824809

PTPN13, a fas-associated protein tyrosine phosphatase, is located on the long arm of chromosome 4 at band q21.3.

J Inazawa1, T Ariyama, T Abe, T Druck, M Ohta, K Huebner, J Yanagisawa, J C Reed, T Sato.   

Abstract

PTPN13 is a protein tyrosine phosphatase that associates with the C-terminal negative regulatory domain in the Fas (APO-1/CD95) receptor. The PTPN13 protein contains six GLGF repeats that have been found in the rat postsynaptic density protein (PSD-95) and the Drosophila tumor suppressor protein, lethal-(1)-disc-large-1 (dlg-1). The localization of the PTPN13 gene to human chromosome 4q21.3 was determined by both FISH and PCR analysis of somatic cell hybrids. This 4q21.3 chromosomal region contains a gene for autosomal dominant polycystic kidney disease as well as the region frequently deleted in liver and ovarian cancers, suggesting that PTPN13 is a candidate for one of the putative tumor suppressor genes on the long arm of chromosome 4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8824809     DOI: 10.1006/geno.1996.0039

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  12 in total

1.  PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

Authors:  Murielle Glondu-Lassis; Mathilde Dromard; Magali Lacroix-Triki; Philippe Nirdé; Carole Puech; Dora Knani; Dany Chalbos; Gilles Freiss
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  PDZ motifs in PTP-BL and RIL bind to internal protein segments in the LIM domain protein RIL.

Authors:  E Cuppen; H Gerrits; B Pepers; B Wieringa; W Hendriks
Journal:  Mol Biol Cell       Date:  1998-03       Impact factor: 4.138

3.  The leukemia-associated fusion protein Tel-platelet-derived growth factor receptor β (Tel-PdgfRβ) inhibits transcriptional repression of PTPN13 gene by interferon consensus sequence binding protein (Icsbp).

Authors:  Weiqi Huang; Liping Hu; Ling Bei; Elizabeth Hjort; Elizabeth A Eklund
Journal:  J Biol Chem       Date:  2012-01-18       Impact factor: 5.157

Review 4.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

5.  LOH analysis of genes around D4S2964 identifies ARD1B as a prognostic predictor of hepatocellular carcinoma.

Authors:  Guo-Liang Huang; Bin-Kui Li; Mei-Yin Zhang; Hui-Zhong Zhang; Rong-Rong Wei; Yun-Fei Yuan; Ming Shi; Xiao-Qian Chen; Long Huang; An-Hua Li; Bi-Jun Huang; Hong-Hua Li; Hui-Yun Wang
Journal:  World J Gastroenterol       Date:  2010-04-28       Impact factor: 5.742

6.  Tumor suppress genes screening analysis on 4q in sporadic colorectal carcinoma.

Authors:  Li-Xin Jiang; Jie Xu; Zhao-Wen Wang; Da-Peng Li; Zhi-Hai Peng; Jian-Jun Gao; Lin He; Hai-Tao Zheng
Journal:  World J Gastroenterol       Date:  2008-09-28       Impact factor: 5.742

7.  Association of protein-tyrosine phosphatase PTP-BAS with the transcription-factor-inhibitory protein IkappaBalpha through interaction between the PDZ1 domain and ankyrin repeats.

Authors:  K Maekawa; N Imagawa; A Naito; S Harada; O Yoshie; S Takagi
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

8.  Expression of the putative tumor suppressor gene PTPN13/PTPL1 is an independent prognostic marker for overall survival in breast cancer.

Authors:  Françoise Révillion; Carole Puech; Fanja Rabenoelina; Dany Chalbos; Jean-Philippe Peyrat; Gilles Freiss
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

9.  Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.

Authors:  A Rashid; J S Wang; G S Qian; B X Lu; S R Hamilton; J D Groopman
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

10.  High PTPN13 expression in high grade serous ovarian carcinoma is associated with a better patient outcome.

Authors:  Véronique D'Hondt; Magalie Lacroix-Triki; Marta Jarlier; Florence Boissiere-Michot; Carole Puech; Peter Coopman; Dionyssios Katsaros; Gilles Freiss
Journal:  Oncotarget       Date:  2017-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.